BioStem Technologies Announces $3M Private Placement
BioStem Technologies (BSEM) announced a private placement of 735,296 common shares at $4.08 per share under Nasdaq's at-the-market rules. The offering also includes Series A and Series B warrants to purchase additional shares. The transaction is expected to raise approximately $3 million in gross proceeds for the company. This financing will likely be used to support ongoing operations, research initiatives, or other corporate purposes typical of biotechnology firms seeking capital infusions. From a market perspective, this move reflects BioStem's strategy to secure funding through equity offerings without triggering more disruptive fundraising methods.
Tickers: $BSEM
Topics: private placement stock offering warrants